Kopran Limited (NSE:KOPRAN)
188.05
-4.08 (-2.12%)
May 22, 2025, 3:29 PM IST
Kopran Revenue
In the fiscal year ending March 31, 2025, Kopran had annual revenue of 6.31B INR with 2.72% growth. Kopran had revenue of 1.73B in the quarter ending March 31, 2025, a decrease of -7.28%.
Revenue
6.31B
Revenue Growth
+2.72%
P/S Ratio
1.45
Revenue / Employee
7.50M
Employees
842
Market Cap
9.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.31B | 167.02M | 2.72% |
Mar 31, 2024 | 6.15B | 636.05M | 11.54% |
Mar 31, 2023 | 5.51B | 734.66M | 15.38% |
Mar 31, 2022 | 4.78B | -142.93M | -2.91% |
Mar 31, 2021 | 4.92B | 1.32B | 36.81% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 271.45B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |